← Every company

Regeneron Pharmaceuticals Inc SEC Filings

What Regeneron Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

REGN overview →
Filings on file
142
since Nov 4, 2016
Warning signs
0
none filed
Last results
Oct 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Oct 6, 2026
Results announcedMaterial agreement
8-K
Read ↗
Sep 30, 2026
Executive or director change
8-K
Read ↗
Jul 30, 2026
Quarterly report
10-Q
Read ↗
Jul 30, 2026
Results announced
8-K
Read ↗
Jul 6, 2026
Results announced
8-K
Read ↗
Jun 17, 2026
Shareholder vote
8-K
Read ↗
Apr 29, 2026
Quarterly report
10-Q
Read ↗
Apr 29, 2026
Results announced
8-K
Read ↗
Apr 8, 2026
Results announced
8-K
Read ↗
Feb 4, 2026
Annual report
10-K
Read ↗
Jan 30, 2026
Results announced
8-K
Read ↗
Jan 12, 2026
Results announced
8-K
Read ↗
Oct 28, 2025
Quarterly report
10-Q
Read ↗
Oct 28, 2025
Results announced
8-K
Read ↗
Oct 6, 2025
Results announced
8-K
Read ↗
Aug 1, 2025
Quarterly report
10-Q
Read ↗
Aug 1, 2025
Results announced
8-K
Read ↗
Jun 18, 2025
Shareholder vote
8-K
Read ↗
Apr 29, 2025
Quarterly report
10-Q
Read ↗
Apr 29, 2025
Results announced
8-K
Read ↗
Feb 5, 2025
Annual report
10-K
Read ↗
Feb 4, 2025
Results announced
8-K
Read ↗
Jan 13, 2025
Results announced
8-K
Read ↗
Oct 31, 2024
Quarterly report
10-Q
Read ↗
Oct 31, 2024
Results announced
8-K
Read ↗
Oct 7, 2024
Results announced
8-K
Read ↗
Aug 1, 2024
Quarterly report
10-Q
Read ↗
Aug 1, 2024
Results announced
8-K
Read ↗
Jul 8, 2024
Results announced
8-K
Read ↗
Jun 20, 2024
Shareholder vote
8-K
Read ↗
May 2, 2024
Quarterly report
10-Q
Read ↗
May 2, 2024
Results announced
8-K
Read ↗
Feb 5, 2024
Annual report
10-K
Read ↗
Feb 2, 2024
Results announced
8-K
Read ↗
Jan 31, 2024
Executive or director change
8-K
Read ↗
Jan 8, 2024
Results announced
8-K
Read ↗
Nov 2, 2023
Quarterly report
10-Q
Read ↗
Nov 2, 2023
Results announced
8-K
Read ↗
Oct 5, 2023
Results announced
8-K
Read ↗
Sep 8, 2023
Shareholder vote
8-K/A
Read ↗
Sep 8, 2023
Executive or director change
8-K
Read ↗
Aug 25, 2023
Tender offer
SC TO-T
Read ↗
Aug 3, 2023
Quarterly report
10-Q
Read ↗
Aug 3, 2023
Results announced
8-K
Read ↗
Jun 14, 2023
Shareholder vote
8-K
Read ↗
May 4, 2023
Quarterly report
10-Q
Read ↗
May 4, 2023
Results announced
8-K
Read ↗
Apr 17, 2023
Executive or director change
8-K
Read ↗
Apr 10, 2023
Results announced
8-K
Read ↗
Mar 29, 2023
Material agreementNew debt
8-K
Read ↗
Feb 6, 2023
Annual report
10-K
Read ↗
Feb 3, 2023
Results announced
8-K
Read ↗
Jan 9, 2023
Results announced
8-K
Read ↗
Dec 20, 2022
Material agreementNew debt
8-K
Read ↗
Nov 3, 2022
Quarterly report
10-Q
Read ↗
Nov 3, 2022
Results announced
8-K
Read ↗
Oct 3, 2022
Executive or director change
8-K
Read ↗
Aug 3, 2022
Quarterly report
10-Q
Read ↗
Aug 3, 2022
Results announced
8-K
Read ↗
Jun 15, 2022
Shareholder vote
8-K
Read ↗
Jun 2, 2022
Material agreement
8-K
Read ↗
May 4, 2022
Quarterly report
10-Q
Read ↗
May 4, 2022
Results announced
8-K
Read ↗
May 2, 2022
Tender offer
SC TO-T
Read ↗
Mar 8, 2022
Material agreementNew debt
8-K
Read ↗
Feb 7, 2022
Annual report
10-K
Read ↗
Feb 4, 2022
Results announced
8-K
Read ↗
Jan 10, 2022
Results announced
8-K
Read ↗
Nov 4, 2021
Quarterly report
10-Q
Read ↗
Nov 4, 2021
Results announced
8-K
Read ↗
Sep 16, 2021
Material agreement
8-K
Read ↗
Aug 5, 2021
Quarterly report
10-Q
Read ↗
Aug 5, 2021
Results announced
8-K
Read ↗
Jun 16, 2021
Shareholder vote
8-K
Read ↗
May 6, 2021
Quarterly report
10-Q
Read ↗
May 6, 2021
Results announced
8-K
Read ↗
Feb 8, 2021
Annual report
10-K
Read ↗
Feb 5, 2021
Results announced
8-K
Read ↗
Jan 15, 2021
Material agreement
8-K
Read ↗
Jan 11, 2021
Results announced
8-K
Read ↗
Jan 5, 2021
Executive or director change
8-K
Read ↗
Nov 5, 2020
Quarterly report
10-Q
Read ↗
Nov 5, 2020
Results announced
8-K
Read ↗
Aug 19, 2020
Material agreement
8-K
Read ↗
Aug 12, 2020
Material agreementNew debt
8-K
Read ↗
Aug 5, 2020
Quarterly report
10-Q
Read ↗
Aug 5, 2020
Results announced
8-K
Read ↗
Jul 7, 2020
Material agreement
8-K
Read ↗
Jun 16, 2020
Executive or director changeShareholder vote
8-K
Read ↗
May 29, 2020
Material agreement
8-K
Read ↗
May 5, 2020
Quarterly report
10-Q
Read ↗
May 5, 2020
Results announced
8-K
Read ↗
Apr 7, 2020
Material agreement
8-K
Read ↗
Feb 7, 2020
Annual report
10-K
Read ↗
Feb 6, 2020
Results announced
8-K
Read ↗
Jan 13, 2020
Results announced
8-K
Read ↗
Nov 5, 2019
Quarterly report
10-Q
Read ↗
Nov 5, 2019
Results announced
8-K
Read ↗
Aug 6, 2019
Quarterly report
10-Q
Read ↗
Aug 6, 2019
Results announced
8-K
Read ↗
Jun 19, 2019
Shareholder vote
8-K
Read ↗
May 7, 2019
Quarterly report
10-Q
Read ↗
May 7, 2019
Results announced
8-K
Read ↗
May 3, 2019
Material agreementNew debt
8-K
Read ↗
Apr 10, 2019
Material agreement
8-K
Read ↗
Feb 7, 2019
Annual report
10-K
Read ↗
Feb 6, 2019
Results announced
8-K
Read ↗
Jan 7, 2019
Results announcedMaterial agreement
8-K
Read ↗
Dec 17, 2018
Material agreementNew debt
8-K
Read ↗
Nov 6, 2018
Quarterly report
10-Q
Read ↗
Nov 6, 2018
Results announced
8-K
Read ↗
Aug 2, 2018
Quarterly report
10-Q
Read ↗
Aug 2, 2018
Results announced
8-K
Read ↗
Jun 13, 2018
Shareholder vote
8-K
Read ↗
May 3, 2018
Quarterly report
10-Q
Read ↗
May 3, 2018
Results announced
8-K
Read ↗
Feb 8, 2018
Annual report
10-K
Read ↗
Feb 8, 2018
Results announced
8-K
Read ↗
Jan 18, 2018
Executive or director change
8-K
Read ↗
Jan 8, 2018
Results announcedMaterial agreement
8-K
Read ↗
Jan 2, 2018
Executive or director change
8-K
Read ↗
Nov 8, 2017
Quarterly report
10-Q
Read ↗
Nov 8, 2017
Results announced
8-K
Read ↗
Sep 13, 2017
Shareholder vote
8-K/A
Read ↗
Aug 3, 2017
Quarterly report
10-Q
Read ↗
Aug 3, 2017
Results announced
8-K
Read ↗
Jun 14, 2017
Executive or director changeShareholder vote
8-K
Read ↗
May 4, 2017
Quarterly report
10-Q
Read ↗
May 4, 2017
Results announced
8-K
Read ↗
Mar 9, 2017
Material agreementNew debt
8-K
Read ↗
Feb 9, 2017
Annual report
10-K
Read ↗
Feb 9, 2017
Results announced
8-K
Read ↗
Feb 7, 2017
Material agreement
8-K
Read ↗
Jan 31, 2017
Executive or director change
8-K
Read ↗
Jan 9, 2017
Results announced
8-K
Read ↗
Dec 30, 2016
Material agreement
8-K
Read ↗
Dec 21, 2016
Executive or director change
8-K
Read ↗
Nov 25, 2016
Material agreement
8-K
Read ↗
Nov 18, 2016
Material agreement
8-K
Read ↗
Nov 14, 2016
Material agreement
8-K
Read ↗
Nov 4, 2016
Quarterly report
10-Q
Read ↗
Nov 4, 2016
Results announced
8-K
Read ↗

Source: Regeneron Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on REGN

Related datasets